Joint Clinical Trials Office
A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Chaperone-mediated Protein Degrader RNK05047 in Subjects with Advanced Solid Tumors (CHAMP-1)
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 17, 2022
Intra-Arterial (IA) Chemotherapy for Newly Diagnosed, Residual, or Recurrent Atypical Choroid Plexus Papilloma (ACPP) and Choroid Plexus Carcinoma (CPC) Prior to Second-Look Surgery
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 17, 2022
Engage & Connect: A novel, neuroscience-informed streamlined psychotherapy for postpartum depression
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 18, 2022
A Digital Intervention for Post-Stroke Depression and Executive Dysfunction
Study Status:
Open to Enrollment
Primary Investigator:
Date: September 14, 2022
SSRI Impact On Sperm Quality: A Randomized Placebo Controlled Trial
Study Status:
Open to Enrollment
Primary Investigator:
Date: October 11, 2022
Pharmacokinetic Evaluation of Serum Testosterone Concentrations After Administration of Clomiphene Citrate
Study Status:
Open to Enrollment
Primary Investigator:
Date: October 11, 2022
Tissue Collection for Drug Screening and Bioanalysis
Study Status:
Open to Enrollment
Primary Investigator:
Date: October 14, 2022
A Phase I/Ib Study of BP1002 (a Liposomal Bcl-2 Antisense Oligodeoxynucleotide) in Patients with Refractory/Relapsed Acute Myeloid Leukemia (AML)
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 13, 2022
Phase IA Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich’s Ataxia
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 13, 2023
A Phase 1/2a, Open-Label, Multicenter, Nonrandomized, Safety and Anti-Tumor Activity Study of IMM-1-104, A Novel Oral Dual MEK1/2 Inhibitor in Participants with Previously Treated RAS-Mutated Advanced or Metastatic Solid Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 16, 2023